GeneDx (WGS) PT Raised to $118 at TD Cowen, Citing 'Strong Competitive Position'
Tweet Send to a Friend
TD Cowen analyst Dan Brennan raised the price target on GeneDx (NASDAQ: WGS) to $118.00 (from $75.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
